• Activation of CARD8 Inflammasome by DPP8/9 Inhibitors in Res

  2026-05-20

  Johnson et al. reveal that DPP8/9 inhibitors trigger CARD8 inflammasome activation and pyroptosis in human resting lymphocytes, challenging the prevailing view that inflammasome signaling is confined to myeloid cells. This expands the understanding of inflammasome biology and has implications for immune regulation and disease modeling.

• Neuroligin 1 Proteolysis Sustains Social Memory via Cofilin

  2026-05-20

  Liu et al. uncover that maintenance of social memory in mice depends on social interaction-induced proteolytic fragments of Neuroligin 1 (NLG1) in the ventral hippocampus. These findings clarify the molecular link between extracellular signaling, synaptic plasticity, and memory maintenance, offering new directions for neuropsychiatric disorder research.

• NEDD4L E3 Ligase Suppresses Colorectal Cancer Liver Metastas

  2026-05-19

  Dong et al. identify NEDD4L as a critical E3 ubiquitin ligase that inhibits colorectal cancer liver metastasis by targeting PRMT5 for degradation, thereby suppressing the AKT/mTOR pathway. This mechanistic insight reveals a potential preventive strategy for metastasis and underscores the importance of ubiquitin ligase profiling in cancer research.

• ROS-Degradable Lipid Nanoparticles Enable Tumor-Selective mR

  2026-05-19

  This study introduces a combinatorial library of biodegradable lipid nanoparticles engineered to respond to elevated reactive oxygen species (ROS) in tumor cells, enabling selective mRNA delivery and expression. The approach demonstrates enhanced antitumor efficacy by targeting mutant RAS signaling, with significant implications for precision mRNA therapeutics.

• Atorvastatin in Advanced Research: Mechanisms, Ferroptosis,

  2026-05-18

  Explore Atorvastatin as a HMG-CoA reductase inhibitor in cutting-edge research, with new insights into ferroptosis induction and detailed, evidence-based assay protocols. This article delivers unique guidance for cholesterol metabolism and cancer biology investigators.

• Carbohydrate-Decorated Nanoparticles Enhance Macrophage Gene

  2026-05-18

  This study introduces biodegradable nanoparticles surface-modified with specific carbohydrates, significantly improving targeted gene delivery to macrophages. The approach demonstrates high encapsulation efficiency, robust uptake, and effective transfection, with implications for mRNA delivery system research and immune modulation.

• A40926: Dalbavancin Precursor Empowering MRSA & Gonorrhoeae

  2026-05-17

  A40926 is revolutionizing antibiotic discovery by bridging potent Gram-positive and Neisseria gonorrhoeae inhibition with reproducible, genetically-tractable workflows. This guide translates pivotal findings into actionable protocols and troubleshooting for next-generation MRSA and cell wall inhibitor research.

• Affinity-Purified Goat Anti-Mouse IgG (H+L): Precision, Sign

  2026-05-16

  Explore how Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugated, enables robust, quantitative immunodetection in advanced research. This article uniquely bridges molecular specificity and real-world assay sensitivity, offering actionable protocol guidance and novel insights from purinergic signaling studies.

• CFTRinh-172: Precision CFTR Inhibition for Epithelial Resear

  2026-05-15

  CFTRinh-172 from APExBIO offers rapid, selective CFTR inhibition ideal for dissecting chloride channel signaling in epithelial models. This guide details advanced workflows, troubleshooting, and integration with novel trafficking insights for cystic fibrosis and secretory disorder studies.

• Mitoxantrone HCl as a DNA Topoisomerase II Inhibitor: Expand

  2026-05-15

  Explore the multifaceted roles of Mitoxantrone HCl, a DNA topoisomerase II inhibitor, in advanced cancer and stem cell research. Discover novel mechanisms—including ERα DBD-LBD targeting—and actionable assay guidance that set this compound apart.

• Alda 1: Mechanistic Insights and Advanced Protocols for ALDH

  2026-05-14

  Explore the science and advanced protocols behind Alda 1, a potent ALDH2 activator, with an in-depth analysis of its mechanism and recent breakthroughs in cardioprotection and radiation-induced dermatitis mitigation. Distinct from existing guides, this article delivers actionable insights for research assay design.

• ER Stress and Cytokine Storms Drive Prometastatic Tumor Stat

  2026-05-14

  Conod et al. (2022) reveal that tumor cells surviving impending cell death are reprogrammed into stable prometastatic cells (PAMEs), orchestrated by ER stress and cytokine signaling. Their findings clarify how pro-metastatic traits originate within primary tumors and suggest new intervention points for metastasis prevention.

• Gallein: Optimizing G Protein βγ Subunit Inhibition in Trans

  2026-05-13

  Leverage Gallein to precisely dissect GPCR signaling, modulate macrophage polarization, and inhibit cancer metastasis with robust and reproducible workflows. This guide delivers actionable protocols and troubleshooting strategies, translating leading-edge findings into applied research advantages.

• ARCA Cy5 EGFP mRNA (5-moUTP): Quantitative Tools for Live mR

  2026-05-13

  Discover how ARCA Cy5 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA, enables unparalleled quantitative and spatial analysis of mRNA delivery and translation efficiency in mammalian cells. Learn how this tool advances beyond traditional approaches, with evidence-based recommendations for assay optimization.

• Optimizing Cell Assays with EZ Cap™ Cy5 Firefly Luciferase m

  2026-05-12

  This article delivers scenario-driven, evidence-based guidance on overcoming cell assay reproducibility and sensitivity challenges with EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) (SKU R1010). By addressing common pitfalls in mRNA delivery, immune activation, and assay interpretation, we demonstrate how this 5-moUTP modified, Cap1-capped, Cy5-labeled mRNA streamlines workflow and data reliability for biomedical researchers.

15882 records 1/1059 page Next 12345 下5页 Last page